The short version of Certificate of analysis fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-30 and is reviewed periodically as new material appears.
The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.
Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.
Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.
The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.
| Property | Value | Notes |
|---|---|---|
| Peptide sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Seven residues; tuftsin plus a Pro-Gly-Pro tail |
| Molecular formula | C33H57N11O9 | Commonly reported value for the free peptide |
| Monoisotopic mass | Roughly 751.4 Da | Average molecular mass near 751.9 Da |
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid |
| Solubility class | Freely soluble in water | Also dissolves in saline and other polar solvents |
Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.
Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.
Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
The Tanukhids were Christianised in the 3rd or 4th centuries, likely while in the eastern half of the Fertile Crescent, and by the 4th century they were described as having a "fanatic zeal for Christianity" and were "zealous Christian soldiers" in the 6th century. In the 7th century, during the Muslim conquest of the Levant, the Tanukhids fought with the Romans against the Muslims, including in the Battle of Yarmouk. After Yarmouk, their status as foederati ended. They were described as an "autonomous Christian community in Bilad al-Sham" up until the reign of the Abbasid caliph al-Mahdi (r. 775–785), after which they appear as Muslims. Their conversion to Islam is believed to have been forced upon them by al-Mahdi. They are reported to have been devoted to Christianity, Thomas the Apostle and monasticism, with many monasteries associated with the tribe. Epistle 50, one of the Epistles of Wisdom composed by Druze missionaries in the early 11th century, was explicitly directed to three Tanukhid emirs settled in the mountainous Gharb area southeast of Beirut, calling on them to continue the tradition of their ancestors in spreading Druze teachings. The Gharb was less rugged than the neighboring areas to the north and south, and its strategic value stemmed from its control of Beirut's southern harbor and the road connecting Beirut with Damascus. The warrior peasants who inhabited the Gharb subscribed to the Druze faith, an esoteric offshoot of Isma'ili Shia Islam, the religion of the Fatimid caliphs of Egypt.
The laurel oil is added at the end of the process, and after it is mixed in, the mix is taken from the vat and poured over a large sheet of waxed paper on the floor of the factory. At this point, the soap is a large, green, flat mass, and it is allowed to cool down and harden for about a day. While the soap is cooling, workers with planks of wood strapped to their feet walk over the soap to try to smooth out the batch and make it an even thickness.
=== Modern history === During South Korea's involvement in the Vietnam War, the industrialization and commercialization of kimchi production became increasingly important because the Korean government wanted to provide rations for its troops. The Korean government requested American help to ensure that South Korean troops, reportedly "desperate" for the food, could obtain it in the field. In 2008, South Korean scientists created a special low-calorie, vitamin-rich "space kimchi" for Yi So-yeon, the first Korean astronaut, to take to space. It was bacteria-free, unlike normal kimchi in which bacteria are essential for fermentation. It was feared that cosmic rays might mutate the bacteria. South Korea developed programs for adult Korean adoptees to return to South Korea and learn about what it means to be Korean. One of these programs was learning how to make kimchi.
Sources: en.wikipedia.org
He created the library's first Young Readers Center in the Jefferson Building in 2009, and the first large-scale summer intern (Junior Fellows) program for university students in 1991. Under Billington, the library sponsored the Gateway to Knowledge in 2010 to 2011, a mobile exhibition to ninety sites, covering all states east of the Mississippi, in a specially designed eighteen-wheel truck. This increased public access to library collections off-site, particularly for rural populations, and helped raise awareness of what was also available online. Billington raised more than half a billion dollars of private support to supplement Congressional appropriations for library collections, programs, and digital outreach. These private funds helped the library to continue its growth and outreach in the face of a 30% decrease in staffing, caused mainly by legislative appropriations cutbacks. He created the library's first development office for private fundraising in 1987. In 1990, he established the James Madison Council, the library's first national private sector donor-support group. In 1987, Billington also asked the Government Accountability Office (GAO) to conduct the first library-wide audit. He created the first Office of the Inspector General at the library to provide regular, independent reviews of library operations. This precedent has resulted in regular annual financial audits at the library; it has received unmodified ("clean") opinions from 1995 onward.
=== Acute kidney injury === Ferroptosis occurs during acute kidney injury in various cellular and animal models. Deficiencies in ferroptosis suppressor enzymes such as GPX4 and FSP1 sensitize kidneys to tubular ferroptosis during kidney IRI, thus inhibition of ferroptosis may be of therapeutic benefit. However, in premenopausal women this therapeutic potential might be limited due to intrinsic anti-ferroptotic effects of estrogen. During chemotherapy treatment, ferroptosis contributes to acute kidney injury. Reagents to image ferroptosis have been developed to monitor anticancer drug-induced acute kidney injury in mouse models.
Orexin receptor antagonists are drugs that block the orexin OX1 and/or OX2 receptors, hence reducing the wakefulness-promoting effects of the orexin system and inducing sleep. Non-selective orexin receptor antagonists including suvorexant, lemborexant, and daridorexant and selective orexin OX2 receptor antagonists like seltorexant have been shown in clinical studies to improve sleep onset, sleep duration, and sleep quality.
Sources: en.wikipedia.org
== Further reading == Merck Sharp and Dohme Corporation (22 May 2013). "Suvorexant Advisory Committee Meeting Briefing Document: Peripheral & Central Nervous System Drugs Advisory Committee Meeting" (PDF). Food and Drug Administration. Archived from the original (PDF) on 12 June 2013. Dimova H, Brar S, Men A (2014). "Application Number: 204569Orig1s000. Clinical Pharmacology/Biopharmaceutics Review. Suvorexant (MK-4305)" (PDF). Center for Drug Evaluation and Research (Food and Drug Administration). Archived from the original (PDF) on 5 March 2022.
where χi denotes the mole fraction of component i. For greater accuracy, the critical point can be calculated using equations of state, such as the Peng–Robinson, or group-contribution methods. Other properties, such as density, can also be calculated using equations of state.
==== Kidney ==== People with end-stage kidney disease can have chronically elevated cardiac troponin T levels, which are linked to a poorer prognosis. Troponin I is less likely to be falsely elevated.
== Bibliography == Agoncillo, Teodoro C. (1990) [1960]. History of the Filipino People (8th ed.). Quezon City: Garotech Publishing. ISBN 971-8711-06-6. Bautista, Alberto Manuel (1952). The Hukbalahap Movement in the Philippines, 1942-1952. University of California. Greenberg, Lawrence M. (1987). "V. Ramon Magsaysay, Edwards Landsdale, and the Jusmag". The Hukbalahap Insurrection: A Case Study of a Successful Anti-Insurgency Operation in the Philippines, 1946–1955. United States Army Center of Military History. Library of Congress Catalog Card Number: 86-600597. Archived from the original on May 21, 2011. Retrieved August 12, 2008. Greenberg, Lawrence M. (1987). "VI. The Insurrection – Phase II (1950–1955)". The Hukbalahap Insurrection: A Case Study of a Successful Anti-Insurgency Operation in the Philippines, 1946–1955. United States Army Center of Military History. Library of Congress Catalog Card Number: 86-600597. Archived from the original on May 21, 2011. Retrieved August 12, 2008. Martinez, Manuel F. (2002). "Mission Possible: Assassinate Quezon – and Mrs. Quezon". Assassinations and Conspiracies: From Rajah Humabon to Imelda Marcos. Pasig: Anvil Publishing, Inc. pp. 138–152. ISBN 971-27-1218-4. McClintock, Michael (1992). "4. Toward a New Counterinsurgency: Philippines, Laos, Vietnam". Instruments of Statecraft: U.S. Guerella Warfare, Counterinsurgency, and Counterterrorism, 1940-1990. Pantheon Books. Valeriano, Napoleon D. "Military Operations". Counter-Guerrilla Seminar Fort Bragg, 15 June 1961.
Sources: en.wikipedia.org
The sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter code. It combines the tetrapeptide tuftsin with a carboxyl-terminal Pro-Gly-Pro extension. This full sequence identifies the molecule more precisely than the research name.
No peptide with this exact sequence has been identified as an endogenous substance. It is a laboratory-designed analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The Pro-Gly-Pro extension has no known natural source.
Proline introduces conformational constraints that make a peptide less accessible to common peptidases. This is a standard stabilization strategy in peptide design. The added residues also increase the distance between the active tuftsin portion and typical cleavage sites.
Selank is a synthetic heptapeptide designed as a stabilized analog of the natural tetrapeptide tuftsin. It has been investigated mainly for anxiolytic and cognitive effects. It is not an approved pharmaceutical in most countries.